The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


GlaxoSmithKline Biologicals S.A.EU/1/02/224/004

Main Information

Trade NameAmbirix
Active SubstancesHepatitis a virus
Hepatitis b surface antigen (hbs ag)
Dosage FormSuspension for injection in pre-filled syringe
Licence HolderGlaxoSmithKline Biologicals S.A.
Licence NumberEU/1/02/224/004

Group Information

ATC CodeJ07BC Hepatitis vaccines
J07BC20 combinations


License statusAuthorised
Licence Issued30/08/2002
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back